Literature DB >> 25450691

TRPM7 is required for ovarian cancer cell growth, migration and invasion.

Jing Wang1, Qian-Jin Liao1, Yi Zhang2, Hui Zhou1, Chen-Hui Luo1, Jie Tang1, Ying Wang1, Yan Tang1, Min Zhao1, Xue-Heng Zhao1, Qiong-Yu Zhang3, Ling Xiao4.   

Abstract

Our previous study demonstrated that the melastatin-related transient receptor potential channel 7 (TRPM7) was highly expressed in ovarian carcinomas and its overexpression was significantly associated with poor prognosis in ovarian cancer patients. However, the function of TRPM7 in ovarian cancer is mostly unknown. In this study, we examined the roles of TRPM7 in ovarian cancer cell proliferation, migration and invasion. We found that short hairpin RNA interference-mediated silence of TRPM7 significantly inhibited cell proliferation, colony formation, migration and invasion in multiple ovarian cancer cell lines. Mechanistic investigation revealed that silence of TRPM7 decreased phosphorylation levels of Akt, Src and p38 and increased filamentous actin and focal adhesion number in ovarian cancer cells. Thus, our results suggest that TRPM7 is required for proliferation, migration and invasion of ovarian cancer cells through regulating multiple signaling transduction pathways and the formation of focal adhesions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Ion channel; Metastasis; Ovarian cancer; TRPM7

Mesh:

Substances:

Year:  2014        PMID: 25450691     DOI: 10.1016/j.bbrc.2014.10.118

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

Review 2.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

3.  Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels.

Authors:  Tiandong Leng; Suizhen Lin; Zhigang Xiong; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-04-15

4.  NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma.

Authors:  Tomonori Sasahira; Yukiko Nishiguchi; Miyako Kurihara-Shimomura; Chie Nakashima; Hiroki Kuniyasu; Tadaaki Kirita
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-20       Impact factor: 4.553

5.  Knockdown of sodium-calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells.

Authors:  Sona Lakshme Balasubramaniam; Anilkumar Gopalakrishnapillai; Nicholas J Petrelli; Sonali P Barwe
Journal:  J Biol Chem       Date:  2017-05-26       Impact factor: 5.157

6.  TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.

Authors:  Jingkao Chen; Yunling Dou; Xiaoke Zheng; Tiandong Leng; Xiaofang Lu; Ying Ouyang; Huawei Sun; Fan Xing; Jialuo Mai; Jiayu Gu; Bingzheng Lu; Guangmei Yan; Jun Lin; Wenbo Zhu
Journal:  Tumour Biol       Date:  2016-09-14

7.  Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.

Authors:  Wen-Liang Chen; Andrew Barszczyk; Ekaterina Turlova; Marielle Deurloo; Baosong Liu; Burton B Yang; James T Rutka; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Oncotarget       Date:  2015-06-30

8.  Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.

Authors:  Xianping Che; Jiangtao Zhan; Fan Zhao; Zunhe Zhong; Mianchuan Chen; Ruifa Han; Yi Wang
Journal:  Biomed Res Int       Date:  2021-07-05       Impact factor: 3.411

9.  Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Authors:  Liang Chen; Rui Cao; Gang Wang; Lushun Yuan; Guofeng Qian; Zhongqiang Guo; Chin-Lee Wu; Xinghuan Wang; Yu Xiao
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.738

10.  Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.

Authors:  Wen-Liang Chen; Ekaterina Turlova; Christopher L F Sun; Ji-Sun Kim; Sammen Huang; Xiao Zhong; Yong-Yuan Guan; Guan-Lei Wang; James T Rutka; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Mar Drugs       Date:  2015-04-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.